Panacos Pharmaceuticals, Inc. Stock Other OTC
Equities
PANC
US69811Q1067
Biotechnology & Medical Research
Sales 2006 | 284K 390K | Sales 2007 | 180K 247K | Capitalization | 42.29M 58.02M |
---|---|---|---|---|---|
Net income 2006 | -38M -52.13M | Net income 2007 | -37M -50.76M | EV / Sales 2006 | 504 x |
Net cash position 2006 | 60.4M 82.87M | Net cash position 2007 | 32.58M 44.7M | EV / Sales 2007 | 53.9 x |
P/E ratio 2006 |
-5.32
x | P/E ratio 2007 |
-1.12
x | Employees | - |
Yield 2006 * |
-
| Yield 2007 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
John R. Barr
CEO | Chief Executive Officer | 67 | - |
Thomas Higgins
DFI | Director of Finance/CFO | 72 | - |
1st Jan change | Capi. | |
---|---|---|
-1.17% | 104B | |
+2.87% | 97.47B | |
+2.13% | 22.25B | |
-14.77% | 21.68B | |
-8.79% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |